SciELO - Scientific Electronic Library Online

vol.60 issue6Prevalence and risk factors for oral human papillomavirus infection in Mexican HIV-infected menThe effect of a booster dose of HPV tetravalent vaccine after 51 months: implications for extended vaccination schedules author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • Have no similar articlesSimilars in SciELO


Salud Pública de México

Print version ISSN 0036-3634


PORTILLO-ROMERO, Alejandra Jalil et al. HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV. Salud pública Méx [online]. 2018, vol.60, n.6, pp.658-665.  Epub Aug 22, 2019. ISSN 0036-3634.


To measure HPV vaccine acceptance in diverse Mexican adult popula­tions, taking into account HIV status.

Materials and methods:

A total of 1 329 men and women, with and without HIV, participated in one of three intervention studies, offering HPV vaccination, carried out in the states of Morelos, Tlaxcala and Mexico City; either the bivalent (Morelos n=103, Tlaxcala n=127) or quadrivalent HPV-vaccine (Mexico City n=1 099) was offered.


HPV vaccine was accepted by 80.3% of participants; acceptance was higher in people living with HIV than those without (84.4 vs. 78%, p=0.004). Women had greater HPV infection knowledge (p<0.0001) than men and slightly higher (p=0.4) vaccine acceptance. The main reason for vaccine non-acceptance among HIV-positive participants was their doctor recommended they not get vaccinated.


Acceptance of HPV-vaccine was high in men and women regardless of HIV status. Even higher rates of acceptability may be achieved by educating healthcare providers to recommend HPV vaccine to their patients.

Keywords : HPV vaccine; acceptability; people living with HIV; women; male.

        · abstract in Spanish     · text in English     · English ( pdf )